article thumbnail

Pharma responds to proposed EU pharmaceutical legislation reform

European Pharmaceutical Review

Pinsent Masons Charlotte Weekes, Senior Associate at Pinsent Masons shared with EPR : “The Commission’s ambitious pharma legislation review is the first significant review of the European system since 2004.” “It "Our concern is that the pharma legislation is not there yet."

article thumbnail

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

pharmaphorum

M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.

Pharma 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A glance back to Pharma Integrates, London 2022 – part ii

pharmaphorum

Run by Life Science Integrates, Pharma Integrates was in its 11th year in 2022. When Milburn and Blair introduced competition in 2004-2008 it did start to make a difference.” And the real heroes of Covid were the pharma industry, not the healthcare system. The health systems are broken, but so is the pharma model. [We]

Pharma 76
article thumbnail

A Pharma Marketing Pioneer, Sander Flaum, Passed Away

Contrarian Sales Techniques

He then launched Flaum Navigators in 2004, which was a consultancy that sought to help clients embrace innovation in medical sales and marketing. In 1988, he transitioned to the agency side of the organization and became the CEO of Euro RSCG Becker. He earned his undergraduate and MBA degrees from The Ohio State University.

article thumbnail

Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict

Pharmaceutical Technology

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation.

Pharma 64
article thumbnail

New Prescription Migraine Drugs Aren’t Resonating with Patients—Here’s How Pharma Can Boost Uptake

PM360

These low adoption rates highlight the need for more migraine-drug awareness and suggest that pharma marketers should explore new strategies to boost patient uptake. Patient self-advocacy is another powerful tool pharma marketers can leverage to stand out in the crowded market space and increase brand adoption.

article thumbnail

How can the pharma industry address the gap in talent recruitment and development?

pharmaphorum

Furthermore, by simulating real-life scenarios, AR offers the chance for staff in the pharma industry to practice complex operations without the associated risks. The pandemic raised the sector’s profile and has helped establish pharma as a desirable career path for several reasons, including job security, innovation, and societal value.